Temporal lobectomy for glioblastoma trial
Part of Brain & nervous system, Cancer clinical trials.
This trial tests if removing part of the temporal lobe (anterior temporal lobectomy) improves outcomes for people with newly diagnosed glioblastoma that is only in the temporal lobe. It aims to see if this surgery can safely remove the entire tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected glioblastoma that shows up on MRI with contrast.
- The tumor is in the temporal lobe and on one side of the brain only.
- You are between 18 and 75 years old.
- You are able to understand the trial and give written consent.
- You must be in good enough health for brain surgery and chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses advanced imaging to help surgeons remove as much of a malignant brain tumor as safely possible. It may be a good fit if you have a new diagnosis of glioblastoma or a certain astrocytoma and are healthy enough for surgery.
This trial is testing whether removing only part of the brain lobe (sub-lobectomy) is effective for a certain type of aggressive brain tumor. It aims to see if this less extensive surgery can help patients with a specific genetic profile.
This trial tests whether wearing a device called Optune (which uses electric fields to slow cancer growth) before surgery helps people with glioblastoma. It is for patients who are fairly active and plan to have standard tumor removal and radiation therapy afterward.
This trial is testing a new way to find and remove glioblastoma brain tumors using a special MRI scan. It may help doctors remove more of the tumor safely during surgery.
This study tests a laser ablation treatment for people whose high-grade glioma (a fast-growing brain tumor) has come back after standard therapy. The goal is to see if this minimally invasive laser procedure can help control the tumor.
This trial tests a combination of MRI-guided laser surgery, a wearable device (Optune) that sends electric fields to the brain, and an immunotherapy drug (pembrolizumab/Keytruda) for people whose glioblastoma has come back. The goal is to see if this approach is safe and works better than standard treatments.
Hear when a new Newly Diagnosed Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.